Clinical Outcomes of Medications Post Anti-TNF: Researching Effectiveness in Pediatric IBD

Go Back to All Clinical Trials

Clinical Outcomes of Medications Post Anti-TNF: Researching Effectiveness in Pediatric IBD

Brief description of study

The purpose of the study is to compare the clinical effectiveness and safety of newer inflammatory bowel disease (IBD) medications in anti-tumor necrosis factor (TNF) refractory patients with pediatric IBD (PIBD).

Clinical Study Identifier: s25-00939

Principal Investigator: Michael Dolinger.

Other Investigators: Kimberly Harrison, Jenna Erin Breit, Libia C. Moy.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies